MYH3

Chr 17ADAR

myosin heavy chain 3

Also known as: CPSFS1A, CPSFS1B, CPSKF1A, CPSKF1B, DA2A, DA2B, DA2B3, DA8

Myosin is a major contractile protein which converts chemical energy into mechanical energy through the hydrolysis of ATP. Myosin is a hexameric protein composed of a pair of myosin heavy chains (MYH) and two pairs of nonidentical light chains. This gene is a member of the MYH family and encodes a protein with an IQ domain and a myosin head-like domain. Mutations in this gene have been associated with two congenital contracture (arthrogryposis) syndromes, Freeman-Sheldon syndrome and Sheldon-Hall syndrome. [provided by RefSeq, Jul 2008]

OMIMResearchGenerating clinical summary…
LOFmechanismAD/ARLOEUF 0.634 OMIM phenotypes
Clinical SummaryMYH3
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
131 unique Pathogenic / Likely Pathogenic· 920 VUS of 1932 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.63LOEUF
pLI 0.000
Z-score 4.70
OE 0.50 (0.400.63)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
1.74Z-score
OE missense 0.85 (0.800.90)
855 obs / 1011.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.50 (0.400.63)
00.351.4
Missense OE?0.85 (0.800.90)
00.61.4
Synonymous OE?1.06
01.21.6
LoF obs/exp: 51 / 102.2Missense obs/exp: 855 / 1011.1Syn Z: -0.97
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongMYH3-related spondylocarpotarsal synostosis syndromeLOFAR
definitiveMYH3-related distal arthrogryposisOTHERAD

This gene — mechanism propensity

DN
0.88top 5%
GOF
0.6540th %ile
LOF
0.2288th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

1932 submitted variants in ClinVar

Classification Summary

Pathogenic60
Likely Pathogenic71
VUS920
Likely Benign651
Benign124
Conflicting90
60
Pathogenic
71
Likely Pathogenic
920
VUS
651
Likely Benign
124
Benign
90
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
45
11
4
0
60
Likely Pathogenic
35
34
2
0
71
VUS
11
823
70
16
920
Likely Benign
1
22
263
365
651
Benign
0
3
105
16
124
Conflicting
90
Total928934443971,916

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

11 pathogenic / likely-pathogenic (of 18) ClinVar copy-number / structural variants overlap MYH3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

MYH3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →